NEUROBLASTOMA IN ADULT: CASE REPORT AND LITERATURE REVIEW
https://doi.org/10.24884/1607-4181-2018-25-2-32-38
Abstract
Neuroblastoma is a malignant tumor derived from the neuroblasts of the sympathetic nervous system, which develop in any region of the nervous system. Usually, neuroblastoma is detected in children aged 1–2 years. About 90% of cases are diagnosed before the age of 5 years. The incidence of adult neuroblastoma is only 0.3 cases per million people per year. The clinical course and biological activity of adult neuroblastoma is different than children neuroblastoma. Early diagnosis of this disease in adults is necessary for timely start of treatment and increasing life expectancy. In this clinical observation, we present a detailed description of the course of this rare disease in the 34-year-old male and literature review on adult neuroblastoma.
About the Authors
E. A. Skorniakova
State Budgetary Institution of Healthcare Leningrad Regional Clinical Hospital;
Pavlov University
45-49, Lunacharsky Avenue, Saint-Petersburg, 194291
45-49, Lunacharsky Avenue, Saint-Petersburg, 194291
L. G. Zaslavskii
State Budgetary Institution of Healthcare Leningrad Regional Clinical Hospital
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
N. A. Neofidov
Pavlov University
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
S. L. Vorobev
Limited Liability Company «Center of Clinical and Morphological Diagnostics»
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
A. A. Gotovchikov
Pavlov University
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
O. V. Rodionova
Pavlov University
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
A. G. Kovelenov
State Budgetary Institution of Healthcare Leningrad Regional Clinical Hospital
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
O. L. Zaslavskaia
Pavlov University
Russian Federation
Saint-Petersburg
Russian Federation
Saint-Petersburg
References
1. Neuroblastoma detailed guide. American Cancer Society. Cancer Facts & Figures 2016. Atlanta, Ga: American Cancer Society. 2016;
2. Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment . Hematol Oncol Clin North Am. 2010;24:65-86. DOI: 10.1016/j.hoc.2009.11.011;
3. Laura Smith, Steve Minter, Paul O’Brien, Jacqueline M Kraveka, Ana Maria Medina, John Lazarchick. Neuroblastoma in an Adult: Case Presentation and Literature Review. Annals of Clinical & Laboratory Science, vol. 43, no. 1, 2013;
4. National cancer institute USA. Neuroblastoma Treatment (PDQ®)–Health Professional Version. Updated: August 25, 2016;
5. NatiaEsiashvili, MD, Michael Goodman, MD, MPH, Kevin Ward, MPH, Robert B. Marcus, Jr., MD, and Peter A.S. Johnstone, MD, MA. Neuroblastoma in Adults: Incidence and Survival Analysis Based on SEER Date. Pediatr Blood Cancer 2007;49:41–46. DOI: 10.1002/pbc.20859;
6. P. C. Davis, R. D. Wichman, Y. Takei, J. C. Hoffman, Jr. Primary Cerebral Neuroblastoma: CT and MR Findings in 12 Cases. AJNR 11:115-120, January/February 1990; AJR 154: April1990;
7. Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: a review. Environ Health Perspect 2007;115(1):138–45. doi: 10.1289/ehp.9023;
8. Baldwin RT, Preston-Martin S. Epidemiology of brain tumors in childhood – a review. Toxicol Appl Pharmacol. 2004;199(2):118-31. DOI: 10.1016/j.taap.2003.12.029;
9. Ana P. Berbegall, Eva Villamón, Irene Tadeo, Tommy Martinsson, Adela Cañete, Victoria Castel, Samuel Navarro and Rosa Noguera. Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration. Neoplasia 2014;16:471–480. doi: 10.1016/j.neo.2014.05.012;
10. Sano H, Bonadio J, Gebring R, et al. International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age. Eur J Cancer. 2006;42:1113-1119. doi:10.1016/j.ejca.2005.11.031;
11. Esiashvili N, Goodman M, Ward K, et al. Neuroblastoma in adults: incidence and survival analysis based on SEER data. Pediatr Blood Cancer. 2007;49:41-46. DOI: 10.1002/pbc.20859;
12. Franks L, Bollen A, Seeger RC, et al. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer. 1997;79:2028-2035. DOI: 10.1002/(SICI)1097-0142(19970515)79:103.0.CO;2-V;
13. Lonergan GJ, Schwab CM, Suarez ES et-al. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 2002;22(4): 911- 34. DOI: 10.1148/radiographics.22.4.g02jl15911;
14. Kushner BH, Kramer K, LaQuaglia MP, et al. Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience. Med Pediatr Oncol. 2003;41:508–515. DOI: 10.1002/mpo.10273;
15. Fatih Selcukbiricik, Deniz Tural, Nihal Esatoglu, Sinem Kocak, and Nil Molinas Mandel. A Very Rare Adult Case with Neuroblastoma. Case Rep Oncol. 2011;4(3):481–486. doi: 10.1159/000332761;
16. Kushner BH, Kramer K, LaQuaglia MP, et al. Neuroblastoma in adolescents and adults: The Memorial Sloan-Kettering experience. Med PediatrOncol 2003;41:508–515. DOI: 10.1002/mpo.10273.
Review
For citations:
Skorniakova E.A., Zaslavskii L.G., Neofidov N.A., Vorobev S.L., Gotovchikov A.A., Rodionova O.V., Kovelenov A.G., Zaslavskaia O.L. NEUROBLASTOMA IN ADULT: CASE REPORT AND LITERATURE REVIEW. The Scientific Notes of the Pavlov University. 2018;25(2):32-38. (In Russ.) https://doi.org/10.24884/1607-4181-2018-25-2-32-38
Views:
11008
Email this article 